HealthSeptember 4, 2026
anagrelide
uh-NAG-ruh-lyde
Definition
A medication used to treat essential thrombocythemia by reducing the number of platelets produced by the bone marrow.
Etymology
The name is a non-proprietary drug designation derived from standard pharmaceutical naming conventions used to identify specific pharmacological compounds, typically developed by combining segments of the chemical name or structural characteristics.
In the news
Anagrelide is mentioned as the last therapy approved for essential thrombocythemia before the recent approval of ropeginterferon alfa-2b, highlighting the long gap in new treatment options for this condition.
Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win
Read the full article ↗MedPage Today